Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PhenoVista logo — PhenoVista combines physiologically-relevant 2D and 3D cell...

PhenoVista

PhenoVista combines physiologically-relevant 2D and 3D cell models and quantitative fluorescence imaging.

Founded 2014 United States San Diego, United States 16 employees Venture round Total: $3.15M Biotechnology, Life Sciences

General Information

Company Name PhenoVista
Founded Year 2014
Location United States San Diego, United States
Employees 16
Industries Biotechnology, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PhenoVista. To contact PhenoVista, visit phenovista.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PhenoVista compare?

A PDF of PhenoVista and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PhenoVista soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PhenoVista

PhenoVista is a San Diego-based biotechnology company that specializes in modern human, cell-based in vitro assay development and analysis. Established in 2014, the company has gained international recognition for its expertise in developing and implementing fully bespoke projects and pre-validated Ready-2-Go assay services. PhenoVista leverages high-content imaging to enable life scientists to accelerate their discovery of novel therapeutics and improve global health. The company's offerings include 3D Assay Development for a Variety of Cell Types and Models, Human iPS-derived Neuronal Health, Mitochondrial Structure and Function, Uptake and Subcellular Localization of Therapeutic Antibodies, Differentiation of Human Primary Cells, Metabolic Function and Disorders, and Immuno-oncology Screens. PhenoVista recently received a $3.00M Venture Round investment on 13 December 2022 from Fujifilm Healthcare Americas Corporation. With its focus on physiologically-relevant 2D and 3D cell models and quantitative fluorescence imaging, PhenoVista is poised to make significant strides in the biotechnology industry with the support of this investment. For further details, interested parties can visit their website or connect with them on various social media platforms.

Business keywords: Contract Research Organization (CRO), High Content Imaging, Phenotypic Assay Development, Screening Services, Immuno-oncology, Preclinical Services, Drug Discovery, Cell Based Assays, In Vitro Assays, Fluorescence Microscopy, Neurobiology, Cell Health, Cell Models, Fibrosis, Cell & Gene Therapy

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $3.00M 1
Life Sciences Corporate Venture Capital
13 Dec 2022
Venture Round Undisclosed 1
BroadOak Capital Partners
BroadOak Capital Partners
18 Jan 2022
Grant $149.80K 1
U.S. Department of Health & Human Services
15 Sep 2017

PhenoVista Alternatives & Competitors

View All Alternatives
PhenoVista vs
InvivoSciences® Inc.
InvivoSciences® Inc. United States

Discovery with Human touch

Non Equity Assistance
4 employees
Biotechnology, Health Care
PhenoVista vs
XenTech
XenTech France

Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years.

Seed
36 employees
Biotechnology, Health Care
PhenoVista vs
IVIM Technology
IVIM Technology Korea South

Global No.1 solution provider of IntraVital Microscopy

Series C
29 employees
Biopharma, Biotechnology
View all alternatives

FAQ About PhenoVista

PhenoVista combines physiologically-relevant 2D and 3D cell models and quantitative fluorescence imaging.
PhenoVista was founded in 2014.
PhenoVista is headquartered in San Diego, United States.
PhenoVista operates in Biotechnology and Life Sciences. Its work centres on Contract Research Organization (CRO), High Content Imaging, Phenotypic Assay Development and Screening Services.
PhenoVista has approximately 16 employees.
PhenoVista has completed 3 funding rounds, raising a total of $3.15M. The latest funding stage is Venture round.
Top alternatives and competitors to PhenoVista include InvivoSciences® Inc., XenTech, IVIM Technology, TheraIndx Lifesciences Pvt.Ltd., AlveoliX . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhenoVista and InvivoSciences® Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PhenoVista, https://bouncewatch.com/company/phenovista, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes